PAID ADVERTISEMENT
Clearing the Way from Echo to AVR: Addressing Obstacles to Timely Intervention in Severe Aortic Stenosis
Join the discussion with leading authorities in aortic valve replacement on the latest clinical trial data and expert recommendations, including how to ensure patient access to timely intervention. This CME symposium enables direct interaction with expert faculty to help you stay up-to-date with the recommended timing of optimal, evidence-based treatment delivered before irreversible cardiac damage occurs.
CLINICAL FACULTY:
Patricia A. Pellikka, MD (Chair)
Mayo Clinic, Rochester, MN
Sammy Elmariah, MD, MPH
University of California-San Francisco, CA
Brian R. Lindman, MD, MSc
Vanderbilt University Medical Center, Nashville, TN
Jordan B. Strom, MD, MSc
Harvard Medical School, Boston, MA
LEARNING OBJECTIVES:
- Describe new guidelines for the interpretation and reporting of echocardiographic findings in patients with aortic stenosis (AS)
- Identify and address challenges in the assessment of the severity of AS that may result in delayed referral to and intervention by the heart valve team
- Explain the benefits of transcatheter aortic valve replacement (TAVR) in patients with asymptomatic, severe AS, including the impact of age and cardiac biomarkers on outcomes
- Implement emerging best practices for the management of AS, including enhanced communication between imaging specialists and other members of the heart valve team
This CME Symposium is provided by Haymarket Medical Education and supported by an educational grant from Edwards Lifesciences, LLC.
Click here for more information
This event is not part of the official Scientific Sessions 2025 as planned by the AHA Committee on Scientific Sessions Programming.